{"version":"1.0","type":"link","title":"Neoadjuvant Sintilimab Combined with Gemcitabine and Cisplatin for Muscle-Invasive Bladder Cancer Patients Followed by Selective Bladder Sparing Surgery: A Phase 2 Trial.","author_name":"Tong Z 외","author_url":"https://prs-insight.online/author/Tong%20Z","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167339","thumbnail_width":1200,"thumbnail_height":630}